Practical Approaches for Interrupting Prolonged Sitting to Improve Postprandial Glucose and Protein Metabolism
1 other identifier
interventional
14
1 country
1
Brief Summary
The present study will determine the impact of interrupting prolonged sitting with short, 2-minute walks or body-weight squats on: i) postprandial glycemia and insulinemia, and; ii) postprandial utilization of dietary amino acids. We hypothesize that postprandial glycemia and insulinemia will be similarly improved by interrupting prolonged sitting with short walks or body-weight squats, whereas postprandial utilization of dietary amino acids will only be improved by interrupting prolonged sitting with body-weight squats.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 19, 2018
CompletedFirst Submitted
Initial submission to the registry
March 28, 2019
CompletedFirst Posted
Study publicly available on registry
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedJanuary 19, 2022
January 1, 2022
2.1 years
March 28, 2019
January 18, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Postprandial insulin area under the curve (AUC) to breakfast and lunch
The plasma insulin concentration measured by enzyme-linked immunosorbent assay area under the curve will be measured using the trapezoidal rule.
3 hours postprandial
Secondary Outcomes (2)
Postprandial glucose area under the curve (AUC) to breakfast and lunch
3 hours postprandial
Skeletal muscle dietary protein incorporation
7.5 hours postprandial
Study Arms (3)
Sedentary
EXPERIMENTALSedentary (SED): Participants will remain seated in the lab all-day (7.5 hr).
Walking Breaks
EXPERIMENTALWalking breaks (WALK): Participants will perform 2-minute walking breaks at 3.1 mph on a treadmill every 30 minutes (7.5 hr).
Resistance-exercise breaks
EXPERIMENTALResistance exercise breaks (RE): Participants will perform 15 "squats" (1-minute) every 30 minutes. To reduce the risk of injury, standardize squat-depth, and recruit similar muscle groups as walking, the squats performed will be a "chair-stand with calf-raise" (7.5 hr).
Interventions
Participants will be provided a mixed-macronutrient meal (liquid drink) at hours "0" and "3", mimicking the energy and macronutrient composition of breakfast and lunch in Western society (38). 20% of daily energy intake will be provided as "breakfast" and 30% at lunch. Macronutrient composition will reflect a diet providing 55% energy needs from carbohydrate (CHO) and 1.2g/kg/d protein. The remaining energy requirements, as determined by total energy intake, will be met with dietary fat (estimated to be \~0.2 and 0.3g/kg fat for breakfast and lunch, respectively), similar to previous liquid mixed-meal approaches.
Eligibility Criteria
You may qualify if:
- Men and women between 18-35 yr
- Recreationally active (≤ 150 minutes of moderate-intensity physical activity per week and no more than 3 days/week of exercise)
- VO2peak considered "good" or below based on ACSM age and sex normative values
- Experiencing regular menstrual periods and not taking hormonal oral contraceptives (females only)
You may not qualify if:
- Inability to perform physical activity as determined by the PAR-Q
- Inability to adhere to protocol guidelines (e.g. alcohol, standardized diet)
- Physical limitations for walking or repeatedly rising from a chair
- Regular tobacco use
- Illicit drug use (e.g. growth hormone, testosterone)
- Hormonal oral contraceptive use (females only)
- Diagnosed medical condition under the care of a physician (e.g. type 2 diabetes)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Goldring Center for High Performance Sport
Toronto, Ontario, M5S 2C9, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Moore, Ph.D
University of Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 28, 2019
First Posted
April 1, 2019
Study Start
October 19, 2018
Primary Completion
December 1, 2020
Study Completion
December 1, 2021
Last Updated
January 19, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share